QQQ   271.52 (+2.39%)
AAPL   450.76 (+3.03%)
MSFT   208.86 (+2.69%)
FB   260.05 (+1.53%)
GOOGL   1,503.00 (+1.52%)
AMZN   3,151.84 (+2.31%)
NVDA   454.09 (+4.63%)
CGC   17.37 (+2.48%)
BABA   254.86 (+2.59%)
TSLA   1,512.74 (+10.07%)
GE   6.63 (-1.49%)
MU   48.36 (+1.26%)
AMD   81.85 (+6.46%)
T   30.14 (-0.20%)
F   7.12 (-1.52%)
ACB   9.92 (-1.00%)
GILD   68.77 (+0.98%)
NFLX   478.75 (+2.53%)
DIS   131.09 (+0.46%)
BAC   26.56 (-1.34%)
BA   176.20 (-2.18%)
QQQ   271.52 (+2.39%)
AAPL   450.76 (+3.03%)
MSFT   208.86 (+2.69%)
FB   260.05 (+1.53%)
GOOGL   1,503.00 (+1.52%)
AMZN   3,151.84 (+2.31%)
NVDA   454.09 (+4.63%)
CGC   17.37 (+2.48%)
BABA   254.86 (+2.59%)
TSLA   1,512.74 (+10.07%)
GE   6.63 (-1.49%)
MU   48.36 (+1.26%)
AMD   81.85 (+6.46%)
T   30.14 (-0.20%)
F   7.12 (-1.52%)
ACB   9.92 (-1.00%)
GILD   68.77 (+0.98%)
NFLX   478.75 (+2.53%)
DIS   131.09 (+0.46%)
BAC   26.56 (-1.34%)
BA   176.20 (-2.18%)
QQQ   271.52 (+2.39%)
AAPL   450.76 (+3.03%)
MSFT   208.86 (+2.69%)
FB   260.05 (+1.53%)
GOOGL   1,503.00 (+1.52%)
AMZN   3,151.84 (+2.31%)
NVDA   454.09 (+4.63%)
CGC   17.37 (+2.48%)
BABA   254.86 (+2.59%)
TSLA   1,512.74 (+10.07%)
GE   6.63 (-1.49%)
MU   48.36 (+1.26%)
AMD   81.85 (+6.46%)
T   30.14 (-0.20%)
F   7.12 (-1.52%)
ACB   9.92 (-1.00%)
GILD   68.77 (+0.98%)
NFLX   478.75 (+2.53%)
DIS   131.09 (+0.46%)
BAC   26.56 (-1.34%)
BA   176.20 (-2.18%)
QQQ   271.52 (+2.39%)
AAPL   450.76 (+3.03%)
MSFT   208.86 (+2.69%)
FB   260.05 (+1.53%)
GOOGL   1,503.00 (+1.52%)
AMZN   3,151.84 (+2.31%)
NVDA   454.09 (+4.63%)
CGC   17.37 (+2.48%)
BABA   254.86 (+2.59%)
TSLA   1,512.74 (+10.07%)
GE   6.63 (-1.49%)
MU   48.36 (+1.26%)
AMD   81.85 (+6.46%)
T   30.14 (-0.20%)
F   7.12 (-1.52%)
ACB   9.92 (-1.00%)
GILD   68.77 (+0.98%)
NFLX   478.75 (+2.53%)
DIS   131.09 (+0.46%)
BAC   26.56 (-1.34%)
BA   176.20 (-2.18%)
Log in

TSE:GUDKnight Therapeutics Earnings Date, Estimates & History

C$6.77
+0.07 (+1.04 %)
(As of 08/12/2020 01:17 PM ET)
Add
Compare
Today's Range
C$6.67
Now: C$6.77
C$6.79
50-Day Range
C$6.66
MA: C$6.92
C$7.41
52-Week Range
C$4.73
Now: C$6.77
C$8.88
Volume127,208 shs
Average Volume333,000 shs
Market CapitalizationC$886.45 million
P/E Ratio135.40
Dividend YieldN/A
BetaN/A

Earnings

Knight Therapeutics (TSE:GUD) Earnings Information

Knight Therapeutics last released its earnings results on June 26th, 2020. The reported $0.05 EPS for the quarter, topping analysts' consensus estimates of ($0.08) by $0.13. The business had revenue of $45.84 million for the quarter, compared to analyst estimates of $60.35 million. Knight Therapeutics has generated C$0.05 earnings per share over the last year and currently has a price-to-earnings ratio of 135.4. Knight Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 13th, 2020 based off prior year's report dates.

Knight Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Knight Therapeutics (TSE:GUD) Earnings Estimates

2020 EPS Consensus Estimate: $0.14
2021 EPS Consensus Estimate: $0.15
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20203$0.03$0.06$0.04
Q2 20202$0.03$0.04$0.04
Q3 20202$0.03$0.03$0.03
Q4 20202$0.02$0.04$0.03
Q1 20211$0.03$0.03$0.03
Q2 20211$0.04$0.04$0.04
Q3 20211$0.04$0.04$0.04
Q4 20211$0.04$0.04$0.04

Knight Therapeutics (TSE GUD) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/13/2020
(Estimated)
       
6/26/2020Q1 2020C($0.08)C$0.05C$0.11C$60.35 millionC$45.84 millionN/A
3/30/2020Q4 2019C$0.05C($0.01)C$0.05C$20.60 millionC$3.35 millionN/A
11/12/2019Q3 2019C$0.03C$0.01C$0.04C$2.90 millionC$4.03 millionN/A
8/8/2019Q2 2019C$0.02C$0.13C$0.13C$3.12 millionC$3.20 millionN/A
5/9/2019Q1 2019C$0.03C$0.04C$0.04C$3.06 millionC$2.96 millionN/A
3/14/2019Q4 2018C$0.03C$0.04C$0.08C$2.55 millionC$3.89 millionN/A
11/8/2018Q3 2018C$0.03C$0.03C($0.03)C$2.26 millionC$3.22 millionN/A
8/9/2018Q2 2018C$0.03C$0.03C$0.03C$2.38 millionC$2.24 millionN/A
5/10/2018Q1 2018C$0.03C$0.05C$0.05C$1.76 millionC$3.15 millionN/A
3/15/2018Q4 2017C$0.05C$0.05C$1.98 millionC$2.54 millionN/A
11/9/2017Q3 2017C$0.03C$0.03C$0.03C$2.01 millionC$1.86 millionN/A
5/11/2017Q1 2017C$0.04C$0.04C$0.04C$1.68 millionC$1.75 millionN/A
3/16/2017Q4 2016C$0.04C$0.06C$0.06C$1.20 millionC$1.85 millionN/A
11/10/2016Q3 2016C$0.03C$0.04C$0.04C$0.90 millionC$1.89 millionN/A
8/11/2016Q2 2016C$0.01C$0.04C$0.04C$0.59 millionC$1.14 millionN/A
3/24/2016Q4 2015C$0.03C$0.05C$0.05C$1.20 millionC$0.34 millionN/A
11/11/2015Q3 2015C$0.07C$0.07C$0.10 millionC$0.11 millionN/A
8/12/2015Q2 2015C($0.01)C$0.02C($0.05)C$0.15 millionC$0.33 millionN/A
5/13/2015Q1 2015C$0.06C($0.03)C$0.11 millionC$0.25 millionN/A
11/12/2014Q3 2014C$0.01C$0.01C$0.17 millionC$0.01 millionN/A
8/14/2014Q2 2014C($0.01)C$0.01C$0.01C$0.13 millionC$0.25 millionN/A
5/28/2014Q1 2014C($0.01)C($0.01)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.